MAVERICK CAPITAL LTD

Position in NVS — Novartis AG

CIK 934639 DALLAS, TX

Position in NVS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$4,355,092

+$2,026,113 QoQ

Shares Held

27,789

+82.3% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#290

of 1,603 holders

Holding Since

Mar 2020

8 quarters on record

Healthcare · as of Jun 30, 2026

MAVERICK CAPITAL LTD holds $85,841,776 across 3 Drug Manufacturers - General names. NVS ranks #2 (5.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NVO	Novo Nordisk A S	1,653,872	$79,286,623
2	NVS	Novartis AG This page	27,789	$4,355,092
3	SNY	Sanofi	51,572	$2,200,061

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,355,092	27,789	+82.3%	Shares	Sole	2026-08-14
2026-03-31	$2,328,979	15,247	+37.7%	Shares	Sole	2026-05-15
2025-12-31	$1,526,634	11,073	+34.7%	Shares	Sole	2026-02-13
2025-09-30	$1,054,389	8,222	-51.7%	Shares	Sole	2025-11-14
2024-06-30	$1,813,865	17,038	+297.1%	Shares	Sole	2024-08-14
2024-03-31	$415,068	4,291	+116.0%	Shares	Sole	2024-05-15
2021-03-31	$169,848	1,987	-89.5%	Shares	Sole	2021-05-17
2020-03-31	$1,559,789	18,918	—	Shares	Sole	2020-05-19
No filing history on record for this holder in this stock.